MedTrace Logo

Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days

NCT00946777 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2016-11-18

No results posted yet for this study

Summary

The primary objective is to determine if there is a correlation between reductions in corneal staining and improvements in corneal barrier function.

Conditions

  • Dry Eye

Interventions

OTHER

Systane® Ultra

Systane® Ultra 1-2 drops, 4 times per day for 30 days

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2009-09-30
Completion
2009-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00946777 on ClinicalTrials.gov